VITAQ
Löwenstein Medical Technology S.A.
Application Filed: 2022-11-02
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79360755 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2022-11-02 | Application Filed |
| 2023-01-26 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2023-01-26 | Status: Live/Pending |
| 2023-01-27 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Löwenstein Medical Technology S.A. |
| Address | 18, rue Robert Stümper L-2557 Luxembourg XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0091 | Software for use in healthcare and for medical applications; data analysis software in the field of sleep-related or heart-related disorders; downloadable mobile application software for providing medical data; downloadable mobile application software in the field of medical application for patient monitoring and compliance management in the field of sleep-related respiratory disorders; computer software for controlling medical ventilators; computer software for patient data and treatment data in the field of respiratory diseases and sleep-related respiratory disorders; breathing masks, except for artificial respiration; breathing apparatus, except for artificial respiration; respiratory masks, other than for artificial respiration |
| GS0091 | Downloadable software for organizing, accessing, recording, and evaluating patient data, managing patient files, and managing the operation of medical facilities for use in healthcare and for medical applications; Downloadable software for data analysis software in the field of sleep-related or heart-related disorders; downloadable mobile application software for providing medical data to medical providers; downloadable mobile application software in the field of medicine for patient monitoring and compliance management in the field of sleep-related respiratory disorders; recorded computer software for controlling medical ventilators; recorded computer software for organizing, accessing, recording patient data and treatment data in the field of respiratory diseases and sleep-related respiratory disorders; breathing masks in the nature of gas masks, except for artificial respiration; respiratory masksin the nature of protective industrial respiratory masks, other than for artifical respiration |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2023-01-26 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-01-27 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2023-01-31 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-07-03 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-07-07 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-07-08 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-08-13 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-08-13 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-09-04 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-12-10 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-12-10 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-12-11 | 12 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2023-12-14 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2023-12-14 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-12-14 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2023-12-14 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-12-14 | 17 CNSA O:Outgoing Correspondence |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2024-01-02 | 18 PBCR Z:Deletion |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-03-13 | 19 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2024-03-27 | 20 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-03-27 | 21 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2024-04-02 | 22 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-04-02 | 23 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2024-04-16 | 24 GPNX P: |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2024-05-02 | 25 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2024-05-03 | 26 ETOP T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2024-05-06 | 27 ETOP T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2024-06-18 | 28 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-06-18 | 29 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 